Home
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
    • About
    • Registry
    • E-learning courses
  • News
  • Events
  • Webinars
  • Network
    • Steering Committee
    • Vision and Mission
    • Map
    • Meetings
    • Partners
    • Join us
  • Home
  • Resources

Resources

Selected

No filters selected.

Type of publications
  • Guidelines (30)
  • NITAG documentation (1581)
  • Reports (55)
  • SAGE documentation (211)
  • Scientific publications (111)
  • Systematic reviews (SYSVAC) (2561)
Topics
Regions
  • Africa (255)
  • Americas (756)
  • Eastern Mediterranean (42)
  • Europe (692)
  • South-East Asia (76)
  • Western Pacific (191)
Countries
Diseases
  • Chikungunya (6)
  • Cholera (32)
  • COVID-19 (1408)
  • Dengue (39)
  • Diphtheria (78)
  • Ebola (16)
  • Escherichia coli (ETEC) (2)
  • Haemophilus influenzae type B (66)
  • Hepatitis A (63)
  • Hepatitis B (148)
  • Hepatitis C (4)
  • Hepatitis E (3)
  • Herpes simplex (1)
  • Herpes zoster (62)
  • HIV / AIDS (10)
  • Human papillomavirus (HPV) (449)
  • Influenza (556)
  • Japanese encephalitis (34)
  • Lyme disease, Borreliosis (1)
  • Malaria (27)
  • Measles (123)
  • Meningococcal disease (143)
  • Mpox (45)
  • Mumps (46)
  • Pertussis (100)
  • Pneumococcal disease (260)
  • Poliomyelitis (79)
  • Q fever (1)
  • Rabies (27)
  • Rotavirus (113)
  • RSV (Respiratory syncytial virus) (42)
  • Rubella (63)
  • Salmonella (2)
  • Shigella (1)
  • Smallpox (16)
  • Streptococcus group B (6)
  • Tetanus (56)
  • Tick-borne encephalitis (11)
  • Tuberculosis (71)
  • Typhoid (23)
  • Varicella (68)
  • Yellow fever (40)
  • Zika (1)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
Available to download in languages
2025 ∙ Haute Autorité de Santé
H5N1 zoonotic influenza in France
  • Recommendation
  • France
Download:
  • FR
2025 ∙ Haute Autorité de Santé
Seasonal flu vaccination for people aged 65 and over in France. Role of the Efluelda and Fluad vaccines
  • Recommendation
  • France
  • Influenza
Download:
  • FR
2025 ∙ Haute Autorité de Santé
Papillomavirus vaccination in France: expansion of the catch-up vaccination cohort in men and women up to the age of 26
  • Recommendation
  • France
  • Human papillomavirus (HPV)
Download:
  • FR
2025 ∙ Folkhälsomyndigheten
Recommendations for COVID-19 vaccination from September 1 2025 in Sweden
  • Recommendation
  • Sweden
  • COVID-19
2025 ∙ SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, March 2025: Conclusions and recommendations
  • Meeting report
  • Pneumococcal disease
  • Mpox
  • Herpes zoster
  • Poliomyelitis
Download:
  • EN
2025 ∙ NACI
Updated recommendations on measles post-exposure prophylaxis
  • Recommendation
  • Canada
  • Measles
Download:
  • EN
2025 ∙ WHO
WHO position paper on Respiratory Syncytial Virus (RSV)
  • Position paper
  • RSV (Respiratory syncytial virus)
Download:
  • EN
2025 ∙ Jefferson Jones
Proposed clinical considerations for clesrovimab
  • Background paper
  • United States of America
  • RSV (Respiratory syncytial virus)
Download:
  • EN
2025 ∙ Danielle Moulia
Evidence to Recommendations Framework: Clesrovimab
  • Background paper
  • United States of America
  • RSV (Respiratory syncytial virus)
Download:
  • EN
2025 ∙ Susan Hills
Clinical guidance for use of virus-like particle chikungunya vaccine in pregnant and breastfeeding women
  • Background paper
  • United States of America
  • Chikungunya
Download:
  • EN
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
  • News
  • Events
  • Webinars
  • Network
  • Sign in / Register
National Immunization Technical Advisory Groups
  • Home
  • Resources
  • Diseases
  • Training
  • SYSVAC
  • News
  • Events
  • Webinars
  • Network
© 2025

Footer legal info

  • Legal Notice
Subscription to the monthly updates

On the last Wednesday of every month, we send updates about the latest NITAG recommendations in each region, relevant articles related to NITAG work, and other big announcements. Don’t miss them out!

Loading...